Clinical Trial Update: A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 trial completed evaluating the safety and immunogenicity of two investigational vaccines for Yellow Fever and Rabies in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies
• Yellow Fever

Drugs mentioned

• Investigational Rabies vaccine (AstriVax Therapeutics)
• Investigational Yellow Fever vaccine (AstriVax Therapeutics)

Snippet

Sponsor: AstriVax Therapeutics | Conditions: Yellow Fever, Rabies | Phase 1 | Status: COMPLETED